XML 55 R40.htm IDEA: XBRL DOCUMENT
v3.22.0.1

SEGMENT AND GEOGRAPHIC INFORMATION (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2021
Segment Reporting [Abstract] |
Schedule of Net Sales and Profit, by Segment | Net sales and profit by reportable segment for the years ended December 31, 2021, 2020 and 2019 are as follows:
| Years Ended December 31,
Dollars in thousands | 2021 |  | 2020 |  | 2019
Segment Net Sales |  |  |  |  |
Codman Specialty Surgical | $ | 1,025,232 |  |  | $ | 894,831 |  |  | $ | 996,206 |
Tissue Technologies | 517,216 |  |  | 477,037 |  |  | 521,351 |
Total revenues | $ | 1,542,448 |  |  | $ | 1,371,868 |  |  | $ | 1,517,557 |
Segment Profit |  |  |  |  |
Codman Specialty Surgical | $ | 439,471 |  |  | $ | 356,657 |  |  | $ | 395,019 |
Tissue Technologies | 228,199 |  |  | 159,630 |  |  | 144,638 |
Segment profit | 667,670 |  |  | 516,287 |  |  | 539,657 |
Amortization | (16,914) |  | (27,757) |  | (27,028)
Corporate and other | (453,526) |  |  | (337,160) |  |  | (418,869) |
Operating income | $ | 197,230 |  |  | $ | 151,370 |  |  | $ | 93,760 |
Total revenue, net and long-lived assets (tangible) by major geographic area are summarized below:
Dollars in thousands | United States(1) |  | Europe |  | Asia Pacific |  | Rest of the World |  | Consolidated
Total revenue, net: |  |  |  |  |  |  |  |  |
2021 | $ | 1,089,526 |  |  | $ | 191,327 |  |  | $ | 182,034 |  |  | $ | 79,561 |  |  | $ | 1,542,448 |
2020 | 971,975 |  |  | 172,689 |  |  | 157,174 |  |  | 70,030 |  |  | 1,371,868 |
2019 | 1,077,379 |  |  | 197,468 |  |  | 157,391 |  |  | 85,319 |  |  | 1,517,557 |
Total long-lived assets: |  |  |  |  |  |  |  |  |
2021 | $ | 339,535 |  |  | $ | 55,026 |  |  | $ | 11,289 |  |  | $ | 6,836 |  |  | $ | 412,686 |
2020 | 324,893 |  |  | 38,812 |  |  | 13,121 |  |  | 5,577 |  |  | 382,403 |
(1) Includes long-lived assets in Puerto Rico.
Schedule of Geographic Revenue, by Area | Net sales and profit by reportable segment for the years ended December 31, 2021, 2020 and 2019 are as follows:
| Years Ended December 31,
Dollars in thousands | 2021 |  | 2020 |  | 2019
Segment Net Sales |  |  |  |  |
Codman Specialty Surgical | $ | 1,025,232 |  |  | $ | 894,831 |  |  | $ | 996,206 |
Tissue Technologies | 517,216 |  |  | 477,037 |  |  | 521,351 |
Total revenues | $ | 1,542,448 |  |  | $ | 1,371,868 |  |  | $ | 1,517,557 |
Segment Profit |  |  |  |  |
Codman Specialty Surgical | $ | 439,471 |  |  | $ | 356,657 |  |  | $ | 395,019 |
Tissue Technologies | 228,199 |  |  | 159,630 |  |  | 144,638 |
Segment profit | 667,670 |  |  | 516,287 |  |  | 539,657 |
Amortization | (16,914) |  | (27,757) |  | (27,028)
Corporate and other | (453,526) |  |  | (337,160) |  |  | (418,869) |
Operating income | $ | 197,230 |  |  | $ | 151,370 |  |  | $ | 93,760 |
Total revenue, net and long-lived assets (tangible) by major geographic area are summarized below:
Dollars in thousands | United States(1) |  | Europe |  | Asia Pacific |  | Rest of the World |  | Consolidated
Total revenue, net: |  |  |  |  |  |  |  |  |
2021 | $ | 1,089,526 |  |  | $ | 191,327 |  |  | $ | 182,034 |  |  | $ | 79,561 |  |  | $ | 1,542,448 |
2020 | 971,975 |  |  | 172,689 |  |  | 157,174 |  |  | 70,030 |  |  | 1,371,868 |
2019 | 1,077,379 |  |  | 197,468 |  |  | 157,391 |  |  | 85,319 |  |  | 1,517,557 |
Total long-lived assets: |  |  |  |  |  |  |  |  |
2021 | $ | 339,535 |  |  | $ | 55,026 |  |  | $ | 11,289 |  |  | $ | 6,836 |  |  | $ | 412,686 |
2020 | 324,893 |  |  | 38,812 |  |  | 13,121 |  |  | 5,577 |  |  | 382,403 |
(1) Includes long-lived assets in Puerto Rico.

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration